LYFT vs PRME · P/E 108, rev $5.79B vs rev $3.0M
LYFT Inc (LYFT) versus Prime Medicine, Inc. Common Stock (PRME) — a side-by-side from cached financials, not a winner call.
LYFT Inc (LYFT) is a software - application company listed on US. It is led by David Risher.
Prime Medicine, Inc. Common Stock (PRME) is a biotechnology company listed on NASDAQ.
Latest reported LYFT revenue for 2024-12-31 was $5.79B. Net income was $22.8M. Revenue was up 31.4% from 2023-12-31 to 2024-12-31. LYFT currently screens at market cap $6.79B and trailing P/E 107.7.
Latest reported PRME revenue for 2024-12-31 was $3.0M. Net income was -$195.9M. PRME currently screens at market cap $570.8M.
LYFT currently screens at market cap $6.79B and trailing P/E 107.7. PRME currently screens at market cap $570.8M.
Not investment advice. Open the LYFT and PRME stock pages for the full models.
Not investment advice.